logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Bingeeating Disorder

    FiltersReset Filters
    7 results

    • lisdexamfetamine dimesylate

      (Lisdexamfetamine Dimesylate)
      SpecGx LLC
      Usage: Lisdexamfetamine dimesylate capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and for moderate to severe binge eating disorder (BED) in adults. It is not recommended for weight loss.

    • lisdexamfetamine dimesylate

      (lisdexamfetamine dimesylate)
      Elite Laboratories, Inc.
      Usage: Lisdexamfetamine dimesylate capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older and for moderate to severe binge eating disorder (BED) in adults. It is not recommended for weight loss.

    • lisdexamfetamine dimesylate

      (LISDEXAMFETAMINE DIMESYLATE)
      Sun Pharmaceutical Industries, Inc.
      Usage: Lisdexamfetamine dimesylate is indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and for moderate to severe binge eating disorder (BED) in adults. It is not recommended for weight loss or in children under 6 due to potential risks.

    • lisdexamfetamine dimesylate

      (LISDEXAMFETAMINE DIMESYLATE)
      Rhodes Pharmaceuticals
      Usage: Lisdexamfetamine Dimesylate Capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and moderate to severe binge eating disorder (BED) in adults. Limitations include its unsuitability for weight loss and potential risks in younger pediatric patients.

    • lisdexamfetamine dimesylate

      (LISDEXAMFETAMINE DIMESYLATE)
      Granules Pharmaceuticals Inc.
      Usage: Lisdexamfetamine dimesylate capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and moderate to severe binge eating disorder (BED) in adults. They are not recommended for weight loss or for pediatric patients under 6 years due to potential risks.

    • lisdexamfetamine dimesylate

      (lisdexamfetamine dimesylate)
      Alvogen Inc.
      Usage: Lisdexamfetamine dimesylate capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and moderate to severe binge eating disorder (BED) in adults. It is not recommended for weight loss due to associated cardiovascular risks and lack of established safety.

    • lisdexamfetamine dimesylate

      (Lisdexamfetamine Dimesylate)
      Lannett Company, Inc.
      Usage: Lisdexamfetamine dimesylate capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older and for moderate to severe binge eating disorder (BED) in adults. It is not approved for weight loss.